SCHEMBL24492826

SCHEMBL24492826

c1ccc(-n2c3ccccc3c3cc(-c4cc(-c5cccc(-c6cncc(-c7cccnc7)c6)c5)cc(-c5cccc(-c6cncc(-c7cccnc7)c6)c5)c4)ccc32)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.45
▸ ATM Q13315 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ CYP11B2 P19099 3/20 0.41
▸ CYP19A1 P11511 2/20 0.41
▸ CYP11B1 P15538 2/20 0.41
▸ CYP17A1 P05093 1/20 0.41
▸ MAPT P10636 2/20 0.41
▸ MEN1 O00255 2/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ MKNK1 Q9BUB5 2/20 0.39
▸ MKNK2 Q9HBH9 2/20 0.39
▸ PSIP1 O75475 1/20 0.39
▸ AXL P30530 1/20 0.39
▸ NR4A2 P43354 1/20 0.39
▸ PGR P06401 1/20 0.39
▸ KMO O15229 1/20 0.39
▸ CYP1A2 P05177 3/20 0.39
▸ CYP3A4 P08684 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24493057 0.97 L3MBTL1 (0.47) KDM4EATML3MBTL1CYP11B2CYP19A1
SCHEMBL18717870 0.94 L3MBTL1 (0.46) KDM4EATML3MBTL1CYP11B2CYP19A1
SCHEMBL23057379 0.94 L3MBTL1 (0.51) KDM4EATML3MBTL1CYP11B2CYP19A1
SCHEMBL24493047 0.91 CYP19A1 (0.40) L3MBTL1CYP11B2CYP19A1CYP11B1CYP17A1
SCHEMBL10123884 0.91 CYP11B2 (0.44) KDM4EATML3MBTL1CYP11B2CYP19A1
SCHEMBL19762218 0.91 KDM4E (0.49) KDM4EATML3MBTL1CYP11B2CYP19A1
SCHEMBL18790308 0.91 KDM4E (0.49) KDM4EATML3MBTL1CYP11B2CYP19A1
SCHEMBL19763282 0.90 KDM4E (0.45) KDM4EATML3MBTL1CYP11B2CYP19A1
SCHEMBL24492827 0.90 KDM4E (0.45) KDM4EATML3MBTL1CYP11B2CYP11B1
SCHEMBL8739891 0.90 CYP11B2 (0.45) KDM4EATML3MBTL1CYP11B2CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220177454-A1 TRISUBSTITUTED BENZENE COMPOUND HAVING NITROGEN-CONTAINING HETERO RING IN MOLECULAR TERMINUS AND ORGANIC ELECTROLUMINESCENCE ELEMENT HODOGAYA CHEMICAL CO., LTD. (JP) 2022-06-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220177454-A1 TRISUBSTITUTED BENZENE COMPOUND HAVING NITROGEN-CONTAINING HETERO RING IN MOLECULAR TERMINUS AND ORGANIC ELECTROLUMINESCENCE ELEMENT ETV6, LEF1, TEAD2 KDM4E 688/4885ATM 3566/4885L3MBTL1 1418/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback